Higher serum myostatin levels are associated with lower insulin sensitivity in adults with overweight/obesity
Physiological Reports · 2024-09 · 12 (17)
DOI: 10.14814/phy2.16169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, online erschienen am 11.09.2024. Verfasst von Laura E Dichtel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Myostatin, Insulin Resistance, Obesity, Overweight. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, HHS | National Institutes of Health (NIH), Boston Area Diabetes Endocrinology Research Center (BADERC).
Abstract (Originalsprache)
Myostatin inhibition improves insulin sensitivity in preclinical and clinical models; however, studies investigating the relationship between serum myostatin levels and insulin sensitivity are discrepant. Sensitive and specific myostatin LC–MS/MS assays are now available to accurately assess serum myostatin level in vivo. We sought to determine whether higher serum myostatin levels are independently associated with lower insulin sensitivity in adults with overweight/obesity. Participants included 74 adults, 20–65 years old, BMI ≥ 25 kg/m 2 without type 2 diabetes. Appendicular lean mass (ALM) was measured by dual‐energy x‐ray absorptiometry; visceral adipose tissue (VAT) was measured by computed tomography. Main outcome measures were serum myostatin levels (LC–MS/MS) and insulin sensitivity (Matsuda index). Mean age was 48 ± 12 years, and BMI was 33.1 ± 5.6 kg/m 2 (mean ± SD). Men had higher mean serum myostatin levels versus women (8.3 ± 1.9 vs. 7.2 ± 1.9 ng/mL, p = 0.01) and higher serum myostatin levels were associated with higher ALM ( R = 0.34, p = 0.003). Higher serum myostatin levels were associated with lower Matsuda index ( R = −0.44, p = 0.0004), which remained significant after controlling for BMI, VAT, ALM, and sex. In conclusion, higher serum myostatin levels are independently associated with lower insulin sensitivity in adults with overweight/obesity and may be a marker of or play a mechanistic role in the development of insulin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Melanie S Haines
Förderung
- NIDDK NIH HHS
- HHS | National Institutes of Health (NIH)
- Boston Area Diabetes Endocrinology Research Center (BADERC)
- National Institutes of Health
Zitieren
APA
Dichtel, L. E., Kimball, A., Bollinger, B., Scarff, G., Gerweck, A. V., Bredella, M. A., & Haines, M. S. (2024). Higher serum myostatin levels are associated with lower insulin sensitivity in adults with overweight/obesity. Physiological Reports, 12(17). https://doi.org/10.14814/phy2.16169
Vancouver
Dichtel LE, Kimball A, Bollinger B, Scarff G, Gerweck AV, Bredella MA, et al. Higher serum myostatin levels are associated with lower insulin sensitivity in adults with overweight/obesity. Physiological Reports. 2024;12(17). doi:10.14814/phy2.16169
BibTeX
@article{Dichtel2024,
author = {Dichtel, Laura E and Kimball, Allison and Bollinger, Bryan and Scarff, Geetanjali and Gerweck, Anu V and Bredella, Miriam A and Haines, Melanie S},
title = {Higher serum myostatin levels are associated with lower insulin sensitivity in adults with overweight/obesity},
journal = {Physiological Reports},
year = {2024},
volume = {12},
number = {17},
doi = {10.14814/phy2.16169}
}
EUVIMED